USE OF MAGNESIUM SULPHATE IN PRENATAL PERIOD - HARM OR BENEFIT FOR FETUS


Cite item

Full Text

Abstract

Magnesium is one of the most important bioelements which is necessary for normal functioning of organisms. Magnesium is particularly important during pregnancy. Magnesium deficiency can result in a number of complications for both a woman and a fetus. Magnesium sulphate 25 % solution is widely and successfully applied in a number of obstetric cases. However, its impact on a fetus and a newborn child remains a matter of research and discussions.

About the authors

E N Kamenskaya

Northern State Medical University

Email: E-kamenskaya@yandex.ru
аспирант кафедры неонатологии и перинатологии

G N Chumakova

Northern State Medical University

E A Aivazova

Northern State Medical University

E A Zhuravleva

Northern State Medical University

References

  1. Кошелева Н. Г. Роль гипомагниемии в акушерской патологии и методы ее коррекции // Вестник Российской ассоциации акушеров-гинекологов. 1999. № 1. С. 42—46.
  2. Adam B., Malatyalioglu E., Alvur M., Talu C. Magnesium, zinc and iron levels in pre-eclampsia // J. Matern. Fetal. Med. 2001. Vol. 10, N 4. Р 246-250.
  3. Altman D., Carroli G., Duley L., Farrell B., et al. Magpie Trial Collaboration Group. The Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial // Lancet. 2002. Vol. 359. Р 1877-1890.
  4. Azria E., Tsatsaris V., Goffinet F., Kayem G., Mignon A., Cabrol D. Magnesium sulfate in obstetrics: current data // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2004. Vol. 33, N 6, Pt. 1. Р. 510.
  5. Berger R., Garnier Y. Perinatal brain injury // J. Perinat. Med. 2000. Vol. 28, N 4. Р 261-285.
  6. Bourre J. M. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain // J. Nutr. Health Aging. Part 1: micronutrients. 2006. Vol. 10, N 5. P. 377-385.
  7. Boyle C. A., Yeargin-Allsopp M., Schendel D. E., et al. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1.750 grams // Am. J. Epidemiol. 2000. Vol. 152, N 2. Р 120-124.
  8. Crowther C. A., Hiller J. E., Doyle L. W. Magnesium sulphate for preventing preterm birth in threatened preterm labour // Cochrane Database of Systematic Reviews. 2002. Vol. 4. Art. No.: CD001060.
  9. Dwight J., Deborah G. et al. A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy // N. Engl. J. Med. 2008. N 9. Р 895-905.
  10. Duley L., Gulmezoglu A. M. Magnesium sulphate versus lytic cocktail for eclampsia // Cochrane Database of Systematic Reviews. 2007. Vol. 4. Art. No.: CD002960.
  11. Duley L., Gülmezoglu A. M., Henderson-Smart D. J. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 2. Art. No.: CD000025.
  12. Duley L., Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 3. Art. No.: CD000127.
  13. Duley L., Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia // Cochrane Database of Systematic Reviews. 2003. Vol. 3. Art. No.: CD000128.
  14. Durlach J., Pages N., Bac P., Bara M., Guiet-Bara A. Magnesium deficit and sudden infant death syndrome (SIDS): SIDS due to magnesium deficiency and SIDS due to various forms of magnesium depletion: possible importance of the chronopathological form // Magnes Res. 2002. Vol. 15. Р. 78-269.
  15. Grether J. K., Hoogstrate J., Walsh-Greene E., Nelson K. B. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia // Am. J. Obstet. Gynecol. 2000. Vol. 183, N 3. Р. 717-725.
  16. Gude N. M., Stevenson J. L., Moses E. K., King R. G. Magnesium regulates hypoxia-stimulated apoptosis in the human placenta // Clin. Sci. (Lond). 2000. Vol. 98, N 4. Р. 375-380.
  17. Hallak M., Martinez-Poyer J., Kruger M. L. The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial // Am. J. Obstet. Gynecol. 1999. Vol. 181, N 5. Р 1122-1127.
  18. Herschel M., Mittendorf R. J. Tocolytic magnesium sulfate toxicity and unexpected neonatal death // Perinatol. 2001. Vol. 21, N 4. Р 261-262.
  19. Kamitomo M., Sameshima H., Ikenoue T., Nishibatake M. J. Fetal cardiovascular function during prolonged magnesium sulfate tocolysis // Perinat. Med. 2000. Vol. 28, N 5. Р 377-382.
  20. Kisters K., Barenbrock M., Louwen F., et al. Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia // Am. J. Hypertens. 2000. Vol. 13, N 7. Р 765-769.
  21. Maged M., Steven J. Effects of Antenatal Exposure to Magnesium Sulfate on Neuroprotection and Mortality in Preterm Infants: A Meta-Analysis // Obstet Gynecol. 2009. Vol. 114, N 2, Pt. 1. Р 354-364.
  22. Matsuda Y., Kouno S., Hiroyama Y., et al. Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation // Eur. J. Obstet. Gynecol. Reprod. Biol. 2000. Vol. 91, N 2. Р 159-164.
  23. Mehta R., Petrova A. Intrapartum magnesium sulfate exposure attenuates neutrophil function in preterm neonates // Biol. Neonate. 2006. Vol. 89, N 2. Р 99-103.

Copyright (c) 2013 Ekologiya cheloveka (Human Ecology)


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies